#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hyperadrenocorticism Neuroblastoma Synovial sarcoma Hypotransferrinaemia Hypocalcaemia Hodgkin's disease recurrent Proteus syndrome Nasopharyngeal cancer Cystic fibrosis gastrointestinal disease Philadelphia positive acute lymphocytic leukaemia Von Willebrand's disease B-cell lymphoma refractory Chronic hepatitis B Progressive multifocal leukoencephalopathy Peritoneal neoplasm More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis III – Trials in Disease Friedreich’s ataxia – Trials in Disease Combined immunodeficiency Wolfram syndrome – Trials in Disease Langerhans cell sarcoma – Treatment Burkitt’s lymphoma – Life with Disease Behcet’s syndrome Extranodal marginal zone B-cell lymphoma (MALT type) – Basic Information Familial amyotrophic lateral sclerosis Hereditary motor and sensory neuropathy More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sapablursen Varnimcabtagene Autoleucel Cx-037231 Betula Alba Pollen Extract Urea PROMESTRIENE Alx148 Promazine Hydrochloride Lavender Oil Sodium Sulfate Anhydrous Febuxostat Hemihydrate Phleum Pratense (225) Arachis Hypogaea Flour Buspirone Hydrochloride Vixarelimab Aavanc80-5'Hotof Davutamig Promethazine Hydrochloride ROC-101 HYDROCHLORIDE Aluminium Oxide More therapies…

    Learn about Your Condition

    Lymphangioleiomyomatosis Hypogonadism male Pulmonary fibrosis Barrett's oesophagus Arthralgia Ichthyosis Cutaneous sarcoidosis B-cell lymphoma recurrent Haematological infection Muscle spasticity Supraventricular tachycardia Incisional hernia Diabetic nephropathy Sepsis Neurodermatitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Osteoporosis

  • Study on Zoledronic Acid for Healing After Rotator Cuff Surgery in Patients with Tendon Rupture and Osteoporosis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Tendon injury
    Investigated Drugs:
    • Zoledronic Acid
    Austria

  • Study on the Effects of Stopping Alendronic Acid in Patients with Osteoporosis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteoporosis
    Investigated Drugs:
    • Alendronic Acid
    • Tetracycline Hydrochloride
    Denmark

  • Study on Zoledronic Acid Following Denosumab for Osteoporosis Patients

    Recruiting

    3 1 1
    Investigated Drugs:
    • Zoledronic Acid
    Denmark

  • Study on the Use of Romosozumab and Zoledronic Acid for Treating Osteoporosis in Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteoporosis
    Investigated Drugs:
    • Romosozumab
    • Zoledronic Acid
    Denmark

  • Effect of denosumab versus zoledronic acid on erosion progression in patients with erosive hand osteoarthritis and osteoporosis: a randomized controlled trial

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Osteoporosis
    • Osteoarthritis
    Investigated Drugs:
    • Denosumab
    • Zoledronic Acid Monohydrate
    Italy

  • Study on Dasatinib and Quercetin or Nicotinamide Riboside for Patients with Osteoporosis or Osteopenia

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Osteopenia
    • Osteoporosis
    Investigated Drugs:
    • Dasatinib
    Denmark
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!